Global HIV Diagnosis Market Size, Share, Development, Growth and Demand Forecast to 2023

  • ID: 4340301
  • Report
  • Region: Global
  • 150 pages
  • P&S Market Research
1 of 3
Market Overview

HIV diagnosis refers to the test performed to detect the presence of human immunodeficiency virus (HIV) in humans. HIV attacks the immune system targeting CD4 cells, also known as T cells. T-cells helps the immune system to fight against infections. HIV weakens the immune system of an infected individual by reducing the number of T-cells leading to acquired immunodeficiency syndrome (AIDS). AIDS is the advanced stage of HIV infection, and not everyone suffering from HIV infection has AIDS. As reported by the Centers for Disease Control and Prevention (CDC), people diagnosed with AIDS have their CD4 cell count below 200 cells/mm, and have high viral load. The global HIV diagnosis market has been segmented on the basis of product, application and end user.

On the basis of product, the global market has been segmented into consumables, instruments and software and services used for the diagnosis of HIV. Consumables segment has been the largest segment in the global HIV diagnosis market. Consumables include assays, kits, reagents and others. These kits are available as complete and convenient packed test systems and include a standard operating procedure (SOP). A patient has to follow the instructions carefully to get the desired results. Kits offer rapid, easy to use, sensitive, and reliable detection of HIV infection.

On the basis of type of test, the global HIV diagnosis market has been segmented into antibody test, viral load, CD4, early infant diagnosis and viral identification. Antibody test has been the largest segment in the global market. It further involves HIV-1 screening test, HIV-1 antibody confirmatory test and HIV-2 & group O test.

On the basis of end user, the market has been segmented into diagnostic laboratories, hospitals, research institutes and others. Others comprises of the gene banks, cell banks, biotechnology and pharmaceutical companies and home care settings. Diagnostic laboratories have been the largest end user of the global market.

Market Dynamics

The global HIV diagnosis market is expected to witness a CAGR of 10.6%, during the forecast period. Rising prevalence of HIV/AIDS, growing awareness leading to high number of blood donations and blood transfusions, and advantageous features of point of care instruments and kits are some of the key drivers for the global HIV diagnosis market growth. Increasing healthcare expenditure on HIV and related activities further supports the market growth. On the other hand, the market has been facing certain challenges such as high cost of automated HIV diagnosis procedures and lack of skilled professionals, which may impede its growth, during the forecast period. Growing HIV diagnosis market in emerging economies and increase in the popularity of home-based HIV diagnosis devices are presenting a lucrative market opportunity for the players operating in the global HIV diagnosis market.

Growth Drivers

According to the data published by the Joint United Nations Programme on HIV/AIDS (UNAIDS), the prevalence of HIV/AIDS increased by 2.8 million from year 2011 to 2015, reaching approximately 36.7 million HIV positive people globally. The increasing incidence of the HIV/AIDS would mean more number of people taking the HIV/AIDS diagnosis tests in the future, thereby driving the growth in global HIV diagnosis market.

The increased participation of government associations has raised awareness regarding blood donations and blood transfusions, globally. Some of the major associations including the WHO, International Federation of Red Cross and Red Crescent Societies (IFRC), AABB (formerly known as the American Association of Blood Banks) and American Red Cross have supported blood donor programs and encouraged people to donate blood and blood components. Moreover, various government initiatives have been launched by these associations to increase awareness among people about blood donations. These government associations and initiatives have boosted blood collections through voluntary donation around the world. According to WHO, approximately 92 million blood donations were reported annually in 2011 and the number reached to 108 million in 2014, globally. The compromised use of sterilized needles during blood transfusion leads to increased risk of HIV infection thus, serving as a major driver for the growth of the global HIV diagnosis market. The advent of point-of-care instruments and kits for the diagnosis of HIV infection has boosted the rate of diagnosis of people living with HIV due to their several advantages over the old laboratory testing. Also, the healthcare expenditure on HIV and related activities has increased in many countries over the past few years, especially for the purpose of alleviating the potential epidemic situation of HIV in many low- and middle-income as well as developing countries. This in turn is expected to drive the growth of HIV diagnosis market in these countries.

Competitive Landscape

Some of the key players in the global HIV diagnosis market include Siemens AG, F. Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.

Scope for Customization

Customization is offered as per specific business requirements of clients. Illustrative customization within the scope of this report includes:
  • Period of Analysis - Increase in the study period, including historic and forecast years
  • Geographical Analysis - Increase in country coverage
  • Segment Analysis - More granular coverage related to:
  • Further analysis of product, type of test and end user under HIV diagnosis by region
  • Company Profiles - Wider company coverage in terms of detailed analysis or additional company profiles
  • New custom report - A completely customized report can be provided on the market, specific to a region/ country/ segment
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation By Product
1.3.2 Market Segmentation By Type Of Test
1.3.3 Market Segmentation By End User
1.3.4 Market Segmentation By Geography
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Value
1.4 Key Stakeholders

2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown Of Primary Research Respondents
2.2.1.1 By Region
2.2.1.2 By Industry Participants
2.2.1.3 By Company Type
2.3 Market Size Estimation
2.4 Market Breakdown And Data Triangulation
2.5 Assumptions For The Study

3. Introduction
3.1 Market Segmentation
3.1.1 Overview By Product
3.1.1.1 Consumables
3.1.1.1.1 Assays, Kits & Reagents
3.1.1.1.2 Others
3.1.1.2 Instruments
3.1.1.3 Software And Services
3.1.2 Overview By Type Of Test
3.1.2.1 Antibody Test
3.1.2.1.1 Hiv-1 Screening Test
3.1.2.1.1.1 Elisa
3.1.2.1.1.2 Rapid Test
3.1.2.1.1.3 Home Access Dried Blood Spot
3.1.2.1.2 Hiv-1 Antibody Confirmatory Test
3.1.2.1.2.1 Western Blot Test
3.1.2.1.2.2 Ifa
3.1.2.1.2.3 Lia
3.1.2.1.2.4 Ripa
3.1.2.1.3 Hiv-2 & Group O Test
3.1.2.2 Viral Load
3.1.2.3 Cd4
3.1.2.4 Early Infant Diagnosis
3.1.2.5 Viral Identification
3.1.3 Overview By End User
3.1.3.1 Diagnostic Laboratories
3.1.3.2 Hospitals
3.1.3.3 Research Institutes
3.1.3.4 Others
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rising Prevalence Of Hiv/Aids
3.2.1.2 Growing Awareness Leading To High Number Of Blood Donations And Blood Transfusions
3.2.1.3 Advantageous Features Of Point Of Care Instruments And Kits
3.2.1.4 Rising Healthcare Expenditure On Hiv And Related Activities
3.2.1.5 Impact Analysis Of Drivers On Market Forecast
3.2.2 Restraints
3.2.2.1 High Cost Of Automated Hiv Diagnosis Procedures
3.2.2.2 Lack Of Skilled Professionals
3.2.2.3 Impact Analysis Of Restraints On Market Forecast
3.2.3 Opportunities
3.2.3.1 Growing Hiv Diagnosis Market In Emerging Economies
3.2.3.2 Increase In The Popularity Of Home-Based Hiv Diagnosis Devices
3.3 Porter’S Five Forces Analysis
3.3.1 Bargaining Power Of Buyers
3.3.2 Bargaining Power Of Suppliers
3.3.3 Threat Of New Entrants
3.3.4 Intensity Of Rivalry
3.3.5 Threat Of Substitutes

4. Market Size And Forecast By Product
4.1 Global Hiv Diagnosis Consumables Market
4.1.1 Global Hiv Diagnosis Consumables Market, By Type
4.1.2 Global Hiv Diagnosis Consumables Market, By Region
4.2 Global Hiv Diagnosis Instruments Market
4.2.1 Global Hiv Diagnosis Instruments Market, By Region
4.3 Global Hiv Diagnosis Software & Services Market
4.3.1 Global Hiv Diagnosis Software & Services Market, By Region

5. Market Size And Forecast By Type Of Test
5.1 Global Hiv Diagnosis Antibody Test Market
5.1.1 Global Hiv Diagnosis Antibody Test Market, By Type
5.1.1.1 Global Hiv-1 Screening Test Market
5.1.1.1.1 Global Hiv-1 Screening Test Market, By Type
5.1.1.2 Global Hiv-1 Antibody Confirmatory Test Market
5.1.1.2.1 Global Hiv-1 Antibody Confirmatory Test Market, By Type
5.1.2 Global Hiv Diagnosis Antibody Test Market, By Region
5.2 Global Hiv Diagnosis Viral Load Test Market
5.2.1 Global Hiv Diagnosis Viral Load Test Market, By Region
5.3 Global Hiv Diagnosis Cd4 Test Market
5.3.1 Global Hiv Diagnosis Cd4 Test Market, By Region
5.4 Global Early Infant Diagnosis Test Market
5.4.1 Global Early Infant Diagnosis Test Market, By Region
5.5 Global Viral Identification Test Market
5.5.1 Global Viral Identification Test Market, By Region

6. Market Size And Forecast By End User
6.1 Global Hiv Diagnosis Market For Diagnostic Laboratories
6.1.1 Global Hiv Diagnosis Market For Diagnostic Laboratories, By Region
6.2 Global Hiv Diagnosis Market For Hospitals
6.2.1 Global Hiv Diagnosis Market For Hospitals, By Region
6.3 Global Hiv Diagnosis Market For Research Institutes
6.3.1 Global Hiv Diagnosis Market For Research Institutes, By Region

7. Market Size And Forecast By Geography
7.1 North America Hiv Diagnosis Market
7.1.1 North America Hiv Diagnosis Market, By Product
7.1.2 North America Hiv Diagnosis Market, By Type Of Test
7.1.3 North America Hiv Diagnosis Market, By End User
7.1.4 North America Hiv Diagnosis Market, By Country
7.2 Europe Hiv Diagnosis Market
7.2.1 Europe Hiv Diagnosis Market, By Product
7.2.2 Europe Hiv Diagnosis Market, By Type Of Test
7.2.3 Europe Hiv Diagnosis Market, By End User
7.2.4 Europe Hiv Diagnosis Market, By Country
7.3 Asia-Pacific Hiv Diagnosis Market
7.3.1 Asia-Pacific Hiv Diagnosis Market, By Product
7.3.2 Asia-Pacific Hiv Diagnosis Market, By Type Of Test
7.3.3 Asia-Pacific Hiv Diagnosis Market, By End User
7.3.4 Asia-Pacific Hiv Diagnosis Market, By Country
7.4 Latin America Hiv Diagnosis Market
7.4.1 Latin America Hiv Diagnosis Market, By Product
7.4.2 Latin America Hiv Diagnosis Market, By Type Of Test
7.4.3 Latin America Hiv Diagnosis Market, By End User
7.4.4 Latin America Hiv Diagnosis Market, By Country
7.5 Middle East & Africa (Mea) Hiv Diagnosis Market
7.5.1 Mea Hiv Diagnosis Market, By Product
7.5.2 Mea Hiv Diagnosis Market, By Type Of Test
7.5.3 Mea Hiv Diagnosis Market, By End User

8. Competitive Landscape
8.1 Benchmarking Of Hiv Diagnosis Products By Key Players
8.2 Global Strategic Developments
8.2.1 Merger & Acquisition
8.2.2 Partnership
8.2.3 Product Launch/Approval
8.2.4 Other

9. Company Profiles
9.1 Siemen Ag
9.1.1 Business Overview
9.1.2 Product And Service Offerings
9.2 Abbott Laboratories
9.2.1 Business Overview
9.2.2 Product And Service Offerings
9.3 Merck Kgaa
9.3.1 Business Overview
9.3.2 Product And Service Offerings
9.4 Becton, Dickinson And Company
9.4.1 Business Overview
9.4.2 Product And Service Offerings
9.5 Hologic Inc.
9.5.1 Business Overview
9.5.2 Product And Service Offerings
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 Business Overview
9.6.2 Product And Service Offerings
9.7 Thermo Fisher Scientific Inc.
9.7.1 Business Overview
9.7.2 Product And Service Offerings
9.8 Danaher Corporation
9.8.1 Business Overview
9.8.2 Product And Service Offerings
9.9 Bio-Rad Laboratories, Inc.
9.9.1 Business Overview
9.9.2 Product And Service Offerings
9.10 Alere, Inc.
9.10.1 Business Overview
9.10.2 Product And Service Offerings

10. Appendix
10.1 Abbreviations

List Of Tables
Table 1 Analysis Period Of The Study
Table 2 Drivers For The Market: Impact Analysis
Table 3 Restraints For The Market: Impact Analysis
Table 4 Global Hiv Diagnosis Market, By Product, $M (2013-2016)
Table 5 Global Hiv Diagnosis Market, By Product, $M (2017-2023)
Table 6 Global Hiv Diagnosis Consumables Market, By Type, $M (2013-2016)
Table 7 Global Hiv Diagnosis Consumables Market, By Type, $M (2017-2023)
Table 8 Global Hiv Diagnosis Consumables Market, By Region, $M (2013-2016)
Table 9 Global Hiv Diagnosis Consumables Market, By Region, $M (2017-2023)
Table 10 Global Hiv Diagnosis Instruments Market, By Region, $M (2013-2016)
Table 11 Global Hiv Diagnosis Instruments Market, By Region, $M (2017-2023)
Table 12 Global Hiv Diagnosis Software & Services Market, By Region, $M (2013- 2016)
Table 13 Global Hiv Diagnosis Software & Services Market, By Region, $M (2017- 2023)
Table 14 Global Hiv Diagnosis Market, By Type Of Test, $M (2013-2016)
Table 15 Global Hiv Diagnosis Market, By Type Of Test, $M (2017-2023)
Table 16 Global Hiv Diagnosis Antibody Test Market, By Type, $M (2013-2016)
Table 17 Global Hiv Diagnosis Antibody Test Market, By Type, $M (2017-2023)
Table 18 Global Hiv-1 Screening Test Market, By Type, $M (2013-2016)
Table 19 Global Hiv-1 Screening Test Market, By Type, $M (2017-2023)
Table 20 Global Hiv-1 Antibody Confirmatory Test Market, By Type, $M (2013-2016)
Table 21 Global Hiv-1 Antibody Confirmatory Test Market, By Type, $M (2017-2023)
Table 22 Global Hiv Diagnosis Antibody Test Market, By Region, $M (2013-2016)
Table 23 Global Hiv Diagnosis Antibody Test Market, By Region, $M (2017-2023)
Table 24 Global Hiv Diagnosis Viral Load Test Market, By Region, $M (2013-2016)
Table 25 Global Hiv Diagnosis Viral Load Test Market, By Region, $M (2017-2023)
Table 26 Global Hiv Diagnosis Cd4 Test Market, By Region, $M (2013-2016)
Table 27 Global Hiv Diagnosis Cd4 Test Market, By Region, $M (2017-2023)
Table 28 Global Early Infant Diagnosis Test Market, By Region, $M (2013-2016)
Table 29 Global Early Infant Diagnosis Test Market, By Region, $M (2017-2023)
Table 30 Global Viral Identification Test Market, By Region, $M (2013-2016)
Table 31 Global Viral Identification Test Market, By Region, $M (2017-2023)
Table 32 Global Hiv Diagnosis Market, By End User, $M (2013-2016)
Table 33 Global Hiv Diagnosis Market, By End User, $M (2017-2023)
Table 34 Global Hiv Diagnosis Market For Diagnostic Laboratories, By Region, $M (2013-2016)
Table 35 Global Hiv Diagnosis Market For Diagnostic Laboratories, By Region, $M (2017-2023)
Table 36 Global Hiv Diagnosis Market For Hospitals, By Region, $M (2013-2016)
Table 37 Global Hiv Diagnosis Market For Hospitals, By Region, $M (2017-2023)
Table 38 Global Hiv Diagnosis Market For Research Institutes, By Region, $M (2013 -2016)
Table 39 Global Hiv Diagnosis Market For Research Institutes, By Region, $M (2017 -2023)
Table 40 North America Hiv Diagnosis Market, By Product, $M (2013-2016)
Table 41 North America Hiv Diagnosis Market, By Product, $M (2017-2023)
Table 42 North America Hiv Diagnosis Market, By Type Of Test, $M (2013-2016)
Table 43 North America Hiv Diagnosis Market, By Type Of Test, $M (2017-2023)
Table 44 North America Hiv Diagnosis Market, By End User, $M (2013-2016)
Table 45 North America Hiv Diagnosis Market, By End User, $M (2017-2023)
Table 46 North America Hiv Diagnosis Market, By Country, $M (2013-2016)
Table 47 North America Hiv Diagnosis Market, By Country, $M (2017-2023)
Table 48 Europe Hiv Diagnosis Market, By Product, $M (2013-2016)
Table 49 Europe Hiv Diagnosis Market, By Product, $M (2017-2023)
Table 50 Europe Hiv Diagnosis Market, By Type Of Test, $M (2013-2016)
Table 51 Europe Hiv Diagnosis Market, By Type Of Test, $M (2017-2023)
Table 52 Europe Hiv Diagnosis Market, By End User, $M (2013-2016)
Table 53 Europe Hiv Diagnosis Market, By End User, $M (2017-2023)
Table 54 Europe Hiv Diagnosis Market, By Country, $M (2013-2016)
Table 55 Europe Hiv Diagnosis Market, By Country, $M (2017-2023)
Table 56 Asia-Pacific Hiv Diagnosis Market, By Product, $M (2013-2016)
Table 57 Asia-Pacific Hiv Diagnosis Market, By Product, $M (2017-2023)
Table 58 Asia-Pacific Hiv Diagnosis Market, By Type Of Test, $M (2013-2016)
Table 59 Asia-Pacific Hiv Diagnosis Market, By Type Of Test, $M (2017-2023)
Table 60 Asia-Pacific Hiv Diagnosis Market, By End User, $M (2013-2016)
Table 61 Asia-Pacific Hiv Diagnosis Market, By End User, $M (2017-2023)
Table 62 Asia-Pacific Hiv Diagnosis Market, By Country, $M (2013-2016)
Table 63 Asia-Pacific Hiv Diagnosis Market, By Country, $M (2017-2023)
Table 64 Latin America Hiv Diagnosis Market, By Product, $M (2013-2016)
Table 65 Latin America Hiv Diagnosis Market, By Product, $M (2017-2023)
Table 66 Latin America Hiv Diagnosis Market, By Type Of Test, $M (2013-2016)
Table 67 Latin America Hiv Diagnosis Market, By Type Of Test, $M (2017-2023)
Table 68 Latin America Hiv Diagnosis Market, By End User, $M (2013-2016)
Table 69 Latin America Hiv Diagnosis Market, By End User, $M (2017-2023)
Table 70 Latin America Hiv Diagnosis Market, By Country, $M (2013-2016)
Table 71 Latin America Hiv Diagnosis Market, By Country, $M (2017-2023)
Table 72 Mea Hiv Diagnosis Market, By Product, $M (2013-2016)
Table 73 Mea Hiv Diagnosis Market, By Product, $M (2017-2023)
Table 74 Mea Hiv Diagnosis Market, By Type Of Test, $M (2013-2016)
Table 75 Mea Hiv Diagnosis Market, By Type Of Test, $M (2017-2023)
Table 76 Mea Hiv Diagnosis Market, By End User, $M (2013-2016)
Table 77 Mea Hiv Diagnosis Market, By End User, $M (2017-2023)
Table 78 Siemen Ag-At A Glance
Table 79 Abbott Laboratories-At A Glance
Table 80 Merck Kgaa-At A Glance
Table 81 Becton, Dickinson And Company-At A Glance
Table 82 Hologic Inc.-At A Glance
Table 83 F. Hoffmann-La Roche Ltd.-At A Glance
Table 84 Thermo Fisher Scientific Inc.-At A Glance
Table 85 Danaher Corporation-At A Glance
Table 86 Bio-Rad Laboratories, Inc.-At A Glance
Table 87 Alere, Inc.-At A Glance

List Of Figures
Fig 1 Research Scope For Global Hiv Diagnosis Market
Fig 2 Research Methodology For The Global Hiv Diagnosis Market
Fig 3 Regional Split Of Primary And Secondary Research
Fig 4 Breakdown Of Primary Research By Region
Fig 5 Breakdown Of Primary Research By Industry Participant
Fig 6 Breakdown Of Primary Research By Company Type
Fig 7 Data Triangulation Approach For The Global Hiv Diagnosis Market
Fig 8 Global Prevalence Of People Living With Hiv Infection, In Millions (2011-2015)
Fig 9 Porter’S Five Forces Analysis Of The Global Hiv Diagnosis Market
Fig 10 Global Hiv Diagnosis Products Market Snapshot (2016)
Fig 11 Global Hiv Diagnosis Market, By Product, $M (2013-2023)
Fig 12 Global Hiv Diagnosis Consumables Market, By Type, $M (2013-2023)
Fig 13 Global Hiv Diagnosis Consumables Market, By Region, $M (2013-2023)
Fig 14 Global Hiv Diagnosis Instruments Market, By Region, $M (2013-2023)
Fig 15 Global Hiv Diagnosis Software & Services Market, By Region, $M (2013-2023)
Fig 16 Global Hiv Diagnosis Market By Type Of Test Snapshot (2016)
Fig 17 Global Hiv Diagnosis Market, By Type Of Test, $M (2013-2023)
Fig 18 Global Hiv Diagnosis Antibody Test Market, By Type, $M (2013-2023)
Fig 19 Global Hiv-1 Screening Test Market, By Type, $M (2013-2023)
Fig 20 Global Hiv-1 Antibody Confirmatory Test Market, By Type, $M (2013-2023)
Fig 21 Global Hiv Diagnosis Antibody Test Market, By Region, $M (2013-2023)
Fig 22 Global Hiv Diagnosis Viral Load Test Market, By Region, $M (2013-2023)
Fig 23 Global Hiv Diagnosis Cd4 Test Market, By Region, $M (2013-2023)
Fig 24 Global Early Infant Diagnosis Test Market, By Region, $M (2013-2023)
Fig 25 Global Viral Identification Test Market, By Region, $M (2013-2023)
Fig 26 Global Hiv Diagnosis End User Market Snapshot (2016)
Fig 27 Global Hiv Diagnosis Market, By End User, $M (2013-2023)
Fig 28 Global Hiv Diagnosis Market For Diagnostic Laboratories, By Region, $M (2013- 2023)
Fig 29 Global Hiv Diagnosis Market For Hospitals, By Region, $M (2013-2023)
Fig 30 Global Hiv Diagnosis Market For Research Institutes, By Region, $M (2013-2023)
Fig 31 Worldwide Major Markets For Hiv Diagnosis
Fig 32 North America Hiv Diagnosis Market Snapshot
Fig 33 Europe Hiv Diagnosis Market Snapshot
Fig 34 Asia-Pacific Hiv Diagnosis Market Snapshot
Fig 35 Latin America Hiv Diagnosis Market Snapshot
Fig 36 Mea Hiv Diagnosis Market Snapshot
Fig 37 Benchmarking Of Hiv Diagnosis Products By Key Players
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll